Prophylactic percutaneous left ventricular assist device in pregnancy.
Cardiomyopathy
ventricular assist device
Journal
Obstetric medicine
ISSN: 1753-495X
Titre abrégé: Obstet Med
Pays: England
ID NLM: 101464191
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
entrez:
17
9
2019
pubmed:
17
9
2019
medline:
17
9
2019
Statut:
ppublish
Résumé
Pregnancy-associated cardiomyopathy can present earlier in gestation than traditionally defined peripartum cardiomyopathy. Management and optimal delivery timing for these patients are not well defined. We present the case of a 30-year-old primigravid at 26 weeks who presented with new onset ventricular tachycardia, biventricular cardiac failure, and severe mitral regurgitation. She was medically stabilized for two weeks prior to delivery with modest improvement in her condition. Due to concern for life-threatening cardiac failure and pulmonary edema at the time of delivery, a percutaneous left ventricular assist device was inserted immediately prior to cesarean delivery. She remained on mechanical circulatory support for 36 h. We discuss considerations regarding use of a percutaneous left ventricular assist device as a novel therapy to support the hemodynamic changes following delivery in parturients with decompensated heart failure.
Identifiants
pubmed: 31523273
doi: 10.1177/1753495X18777346
pii: 10.1177_1753495X18777346
pmc: PMC6734636
doi:
Types de publication
Case Reports
Langues
eng
Pagination
151-152Références
Circulation. 2005 Apr 26;111(16):2050-5
pubmed: 15851613
Ann Thorac Surg. 2010 Apr;89(4):1211-7
pubmed: 20338336
BMJ Case Rep. 2015 Oct 28;2015:null
pubmed: 26511992
Circulation. 2016 Apr 5;133(14):1397-409
pubmed: 27045128
J Am Heart Assoc. 2017 Apr 3;6(4):null
pubmed: 28373243
Obstet Gynecol. 2017 Aug;130(2):366-373
pubmed: 28697109